A novel ex-vivo model for fluorescence guided surgery: Simulating glioma conditions

Reliable in vitro models are used for optoelectronic device development, such as fluorescence detection devices for fluorescence-guided surgery of gliomas. A common approach involves inducing gliomas in animal models, followed by a dosage of 5-ALA which metabolises to Protoporphyrin IX (PpIX) in the glioma, resulting in fluorescence. Although these approaches excel in capturing key biomolecular and physiological features of the tumour, they are inherently indeterministic. This limits the scope of their use for preclinical device development, where consistent and controllable tumour reproduction across multiple animals, over time, is needed. Alternative approaches using fluorescence markers in gelatine provide a simple replication but may fail to capture the complexities of in vivo models. In this study, we introduce an exogenous brain tumour model for assessing PpIX fluorescence detection. The model was developed by injecting a PpIX solution into the cortical region of a resected adult rat brain, where the injection site simulated a tumoral region with elevated PpIX concentration. The created tumoral region had a gradient of concentrations, with a peak at the centre and a decrease towards the tumour margins, akin to glioma in in vivo conditions. The fluorescence profile was compared to in vivo conditions using 5-ALA and correlated well with other reported works, achieving a correlation of R 2 > 0.93. The model’s validity was tested by examining the effect of the solvent, Dimethyl Sulfoxide, on the Autofluorescence (AF) of the brain sample. Additionally, the short-term effect of storage (over 20 h) on AF was analysed. Examinations confirmed that the solvent did not alter AF. The brain sample should be stored in Hank’s Balanced Salt Solution (or an equivalent) and refrigerated to maintain moisture and preserve AF. The model accurately replicated surgical fluorescence conditions and offers a suitable alternative to glioma induction, benefiting the development of fluorescence detection devices across design iterations.

Authors

Institutions

Publication Details

Journal
Journal of Applied Biomedicine
Published
2026-03-14
DOI
https://doi.org/10.1016/j.bbe.2026.03.003
Primary Topic
Photodynamic Therapy Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A novel ex-vivo model for fluorescence guided surgery: Simulating glioma conditions

Jean Pierre Ndabakuranye, Bobbi Fleiss, Arman Ahnood, John Raschke
Journal of Applied Biomedicine
Photodynamic Therapy Research Studies
article

A novel ex-vivo model for fluorescence guided surgery: Simulating glioma conditions

Jean Pierre Ndabakuranye, Bobbi Fleiss, Arman Ahnood, John Raschke
article en

Abstract

Reliable in vitro models are used for optoelectronic device development, such as fluorescence detection devices for fluorescence-guided surgery of gliomas. A common approach involves inducing gliomas in animal models, followed by a dosage of 5-ALA which metabolises to Protoporphyrin IX (PpIX) in the glioma, resulting in fluorescence. Although these approaches excel in capturing key biomolecular and physiological features of the tumour, they are inherently indeterministic. This limits the scope of their use for preclinical device development, where consistent and controllable tumour reproduction across multiple animals, over time, is needed. Alternative approaches using fluorescence markers in gelatine provide a simple replication but may fail to capture the complexities of in vivo models. In this study, we introduce an exogenous brain tumour model for assessing PpIX fluorescence detection. The model was developed by injecting a PpIX solution into the cortical region of a resected adult rat brain, where the injection site simulated a tumoral region with elevated PpIX concentration. The created tumoral region had a gradient of concentrations, with a peak at the centre and a decrease towards the tumour margins, akin to glioma in in vivo conditions. The fluorescence profile was compared to in vivo conditions using 5-ALA and correlated well with other reported works, achieving a correlation of R 2 > 0.93. The model’s validity was tested by examining the effect of the solvent, Dimethyl Sulfoxide, on the Autofluorescence (AF) of the brain sample. Additionally, the short-term effect of storage (over 20 h) on AF was analysed. Examinations confirmed that the solvent did not alter AF. The brain sample should be stored in Hank’s Balanced Salt Solution (or an equivalent) and refrigerated to maintain moisture and preserve AF. The model accurately replicated surgical fluorescence conditions and offers a suitable alternative to glioma induction, benefiting the development of fluorescence detection devices across design iterations.

Journal of Applied BiomedicineVol. 46(2)
Discovery Centre (CA), RMIT University (AU)
Openalex Percentile: Top 22%
Photodynamic Therapy Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.